Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Southern Company Q2 Earnings Beat as Utility Sales GrowPhoto, wide shot, wide-angle lens,  Gas company, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/07ff6859-914a-4fdd-8473-abdbac8978f6.png
Southern Company Q2 Earnings Beat as Utility Sales Grow

Power supplier The Southern Company SO reported second-quarter 2025 earnings per share (excluding certain one-time items) of 91 cents, outperforming the Zacks Consensus Estimate of 87 cents. The

Tyson Foods (TSN) Q3 Earnings and Revenues Surpass Estimates
Tyson Foods (TSN) Q3 Earnings and Revenues Surpass Estimates

Tyson Foods (TSN) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.87 per share a year ago. These figures

Lindblad Expeditions (LIND) Reports Q2 Loss, Beats Revenue Estimates
Lindblad Expeditions (LIND) Reports Q2 Loss, Beats Revenue Estimates

Lindblad Expeditions (LIND) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.48 per share a year ago. These

Petrobras to Report Q2 Earnings: What's in the Offing for the Stock?
Petrobras to Report Q2 Earnings: What's in the Offing for the Stock?

Petróleo Brasileiro S.A. - Petrobras PBR is set to release second-quarter results on Aug. 7. The Zacks Consensus Estimate for earnings is 71 cents per share on revenues of $20.8 billion.

Let us

New Strong Sell Stocks for August 4th
New Strong Sell Stocks for August 4th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Concrete Pumping Holdings BBCP provides concrete pumping services and concrete waste management services primarily in U.S

Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?
Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?

Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $14.75 billion and $5.61 per share

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

DENTSPLY SIRONA Inc. XRAY is scheduled to release second-quarter 2025 results on Aug. 7, before the opening bell.

In the last reported quarter, the company’s earnings beat the Zacks Consensus

Agnico Eagle's Q2 Earnings Beat Estimates on Higher Gold Prices: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Agnico Eagle's Q2 Earnings Beat Estimates on Higher Gold Prices

Agnico Eagle Mines Limited AEM reported adjusted earnings of $1.94 per share for the second quarter of 2025, up from $1.07 in the year-ago quarter. The bottom line topped the Zacks Consensus

Here's How Much a $1000 Investment in eBay Made 10 Years Ago Would Be Worth Today
Here's How Much a $1000 Investment in eBay Made 10 Years Ago Would Be Worth Today

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and

Aurora Cannabis Pre-Q1 Earnings Analysis: Buy, Sell or Hold the Stock?
Aurora Cannabis Pre-Q1 Earnings Analysis: Buy, Sell or Hold the Stock?

Aurora Cannabis ACB is slated to release first-quarter fiscal 2026 results on Aug. 6, before market open. The Zacks Consensus Estimate for earnings and revenues is pegged at 18 cents per share and

Zimmer Biomet to Report Q2 Earnings: Here's What to Expect
Zimmer Biomet to Report Q2 Earnings: Here's What to Expect

Zimmer Biomet Holdings, Inc. ZBH is scheduled to report second-quarter 2025 results on Aug. 7, before market open.

In the last reported quarter, the company’s earnings of $1.81 surpassed the Zacks

Cenovus Energy Q2 Earnings Beat Estimates, Revenues Miss
Cenovus Energy Q2 Earnings Beat Estimates, Revenues Miss

Cenovus Energy Inc. CVE reported second-quarter 2025 adjusted earnings per share of 33 cents, which beat the Zacks Consensus Estimate of 14 cents. The bottom line, however, declined from the

Buy Mid-Cap AI Stock FIVN on Solid Q2 Earnings, Outlook & ValuationPhoto, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
Buy Mid-Cap AI Stock FIVN on Solid Q2 Earnings, Outlook & Valuation

Contact center software solutions provider Five9 Inc. FIVN reported second-quarter 2025 adjusted earnings of $0.76 per share, which beat the Zacks Consensus Estimate by 16.9% and jumped 46.2% year

Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.86 per share a year ago. These figures

Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y
Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y

Huntsman Corporation’s HUN second-quarter 2025 loss (as reported) was 92 cents per share. This compares to earnings of 13 cents per share in the year-ago quarter.  Barring one-time items, adjusted

BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates

BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.06 per share a year ago

Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.86 per share a year ago

How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?

AbbVie ABBV delivered encouraging second-quarter 2025 results last week, sending a clear message — it is effectively managing its post-Humira transition. The stronger-than-expected sales of newer

TG Therapeutics (TGTX) Misses Q2 Earnings Estimates
TG Therapeutics (TGTX) Misses Q2 Earnings Estimates

TG Therapeutics (TGTX) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.04 per share a year ago. These

Wayfair (W) Tops Q2 Earnings and Revenue Estimates
Wayfair (W) Tops Q2 Earnings and Revenue Estimates

Wayfair (W) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.47 per share a year ago. These figures are

Bruker (BRKR) Misses Q2 Earnings Estimates
Bruker (BRKR) Misses Q2 Earnings Estimates

Bruker (BRKR) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.52 per share a year ago. These figures are

Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.92 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to a loss of $1.24 per share a year ago. These figures

Canadian Natural to Report Q2 Earnings: What's in the Offing?
Canadian Natural to Report Q2 Earnings: What's in the Offing?

Canadian Natural Resources Limited CNQ is set to release second-quarter 2025 results on Aug. 7. The Zacks Consensus Estimate for earnings is pegged at 44 cents per share on revenues of $6.28

Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates
Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates

Hagerty, Inc. (HGTY) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.12 per share a year ago. These

Cheniere Energy to Report Q2 Earnings: What's in the Offing?
Cheniere Energy to Report Q2 Earnings: What's in the Offing?

Cheniere Energy, Inc. LNG is set to release second-quarter results on Aug. 7. The Zacks Consensus Estimate for earnings is $2.30 per share on revenues of $4.1 billion.

Let us delve into the factors